sst 0001
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2012 (NCT01764880)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- HeparinSupplementation
Heparin supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- sst0001
- sst0001
- sst 0001
- sst-0001
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01764880 | Phase 1 | Nov 1, 2012 | Leadiant Biosciences, Inc., Tel Aviv University, University of Brescia |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Leadiant Biosciences, Inc. | For profit | 1 | 1 | 1 | 2012 |
| Tel Aviv University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| University of Brescia | Academic/Hospital | 1 | 0 | 1 | 2012 |
3 organizations
Page 1 / 1